Institutional Ownership Intercept Pharmaceuticals, Inc. (ICPT)
This table provides information about the institutional ownership of Intercept Pharmaceuticals, Inc. (ICPT). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 1.04 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
955,005
shares
|
$0
0.01% of portfolio
|
Q2 2023
Added 37.48%
|
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
52,067
shares
|
$0
0.02% of portfolio
|
Q3 2021
Reduced 32.44%
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
31,000
shares
|
$0
0.02% of portfolio
|
Q2 2020
Added 2.48%
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
6
shares
|
$0
0.0% of portfolio
|
Q4 2019
Reduced 99.84%
|